Author: admin

Great Britain is the third major market where donanemab has received approval Donanemab was first approved in the United States in July 2024 and then approved in Japan in September 2024 INDIANAPOLIS, Oct. 23, 2024 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the Medici

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: